accelerate development of a generic version of insulin

From day jobs at such powerhouse facilities as UC San Francisco, Amgen Inc., and Lawrence Livermore National Laboratories, they come to work on the project called Open Insulin. The project aims to accelerate development of a generic version of the lifesaving medicine while showing that citizen scientists and biohackers can contribute an alternative to methods now used by the for-profit pharmaceutical business model, says the group’s 33-year-old co-founder Anthony Di Franco of Berkeley...

Read More »